Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Hope

Showing results (131-140 of 158) with videos related to

Pageof 16
Sort By:
The Journal of Antimicrobial Chemotherapy|September 30, 2022
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settingsChristopher A Darlow, Laura McEntee, Adam Johnson, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 2023
Population pharmacokinetics and CSF penetration of flucytosine in adults with HIV-associated cryptococcal meningoencephalitisKatharine E Stott, Ajisa Ahmadu, Cheusisime Kajanga, et al.
International Journal of Pharmaceutics: X|January 26, 2026
Liposomal antimicrobials in the fight against bacterial and fungal pathogens: Clinical successes and development challengesHussein T Kenaan, Ross M Duncan, Wafa T Al-Jamal, et al.
The Journal of Antimicrobial Chemotherapy|June 28, 2021
Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reportingZahra Sadouki, Timothy D McHugh, Rob Aarnoutse, et al.
Mbio|October 12, 2022
Efficacy of APX2039 in a Rabbit Model of Cryptococcal MeningitisCharles D Giamberardino, Wiley A Schell, Jennifer L Tenor, et al.
Journal of Medicinal Chemistry|September 16, 2025
Novltex: A New Class of Antibiotics with Potent Activity against Multidrug-Resistant Bacterial Pathogens─Design, Synthesis, and Biological EvaluationEsra Malkawi, Anish Parmar, Sanjit Das, et al.
The Journal of Antimicrobial Chemotherapy|October 16, 2024
Population pharmacokinetics/pharmacodynamics of minocycline plus rifampicin in patients with complicated skin and skin structure infections caused by MRSASonia Luque Pardos, William Hope, Antigone Kotsaki, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
Intrapulmonary Pharmacokinetics of Cefepime and Enmetazobactam in Healthy Volunteers: Towards New Treatments for Nosocomial PneumoniaShampa Das, Richard Fitzgerald, Asad Ullah, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial ResistanceChristopher A Darlow, Fernando Docobo-Perez, Nicola Farrington, et al.
Open Forum Infectious Diseases|April 24, 2025
Relative Contribution of Pharmacokinetics and Immune Signatures to Clinical Outcomes in Patients With HIV-associated Cryptococcal MeningitisKatharine E Stott, Dumizulu Tembo, Cheusisime Kajanga, et al.
Pageof 16

Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
The Journal of Antimicrobial Chemotherapy|September 30, 2022
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settingsChristopher A Darlow, Laura McEntee, Adam Johnson, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 2023
Population pharmacokinetics and CSF penetration of flucytosine in adults with HIV-associated cryptococcal meningoencephalitisKatharine E Stott, Ajisa Ahmadu, Cheusisime Kajanga, et al.
International Journal of Pharmaceutics: X|January 26, 2026
Liposomal antimicrobials in the fight against bacterial and fungal pathogens: Clinical successes and development challengesHussein T Kenaan, Ross M Duncan, Wafa T Al-Jamal, et al.
The Journal of Antimicrobial Chemotherapy|June 28, 2021
Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reportingZahra Sadouki, Timothy D McHugh, Rob Aarnoutse, et al.
Mbio|October 12, 2022
Efficacy of APX2039 in a Rabbit Model of Cryptococcal MeningitisCharles D Giamberardino, Wiley A Schell, Jennifer L Tenor, et al.
Journal of Medicinal Chemistry|September 16, 2025
Novltex: A New Class of Antibiotics with Potent Activity against Multidrug-Resistant Bacterial Pathogens─Design, Synthesis, and Biological EvaluationEsra Malkawi, Anish Parmar, Sanjit Das, et al.
The Journal of Antimicrobial Chemotherapy|October 16, 2024
Population pharmacokinetics/pharmacodynamics of minocycline plus rifampicin in patients with complicated skin and skin structure infections caused by MRSASonia Luque Pardos, William Hope, Antigone Kotsaki, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
Intrapulmonary Pharmacokinetics of Cefepime and Enmetazobactam in Healthy Volunteers: Towards New Treatments for Nosocomial PneumoniaShampa Das, Richard Fitzgerald, Asad Ullah, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial ResistanceChristopher A Darlow, Fernando Docobo-Perez, Nicola Farrington, et al.
Open Forum Infectious Diseases|April 24, 2025
Relative Contribution of Pharmacokinetics and Immune Signatures to Clinical Outcomes in Patients With HIV-associated Cryptococcal MeningitisKatharine E Stott, Dumizulu Tembo, Cheusisime Kajanga, et al.
Pageof 16